[go: up one dir, main page]

FR2881654B1 - Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants - Google Patents

Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants

Info

Publication number
FR2881654B1
FR2881654B1 FR0501216A FR0501216A FR2881654B1 FR 2881654 B1 FR2881654 B1 FR 2881654B1 FR 0501216 A FR0501216 A FR 0501216A FR 0501216 A FR0501216 A FR 0501216A FR 2881654 B1 FR2881654 B1 FR 2881654B1
Authority
FR
France
Prior art keywords
ionizing
alkylsulfone
cancer
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0501216A
Other languages
English (en)
Other versions
FR2881654A1 (fr
Inventor
Alex Saunois
Coz Philippe Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethnodyne Fr
Original Assignee
LMD SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LMD SAS filed Critical LMD SAS
Priority to FR0501216A priority Critical patent/FR2881654B1/fr
Publication of FR2881654A1 publication Critical patent/FR2881654A1/fr
Application granted granted Critical
Publication of FR2881654B1 publication Critical patent/FR2881654B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0501216A 2005-02-07 2005-02-07 Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants Expired - Lifetime FR2881654B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0501216A FR2881654B1 (fr) 2005-02-07 2005-02-07 Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501216A FR2881654B1 (fr) 2005-02-07 2005-02-07 Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants

Publications (2)

Publication Number Publication Date
FR2881654A1 FR2881654A1 (fr) 2006-08-11
FR2881654B1 true FR2881654B1 (fr) 2009-05-29

Family

ID=35004267

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0501216A Expired - Lifetime FR2881654B1 (fr) 2005-02-07 2005-02-07 Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants

Country Status (1)

Country Link
FR (1) FR2881654B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
FR2845599B1 (fr) * 2002-10-11 2005-01-07 Lmd Medicament comprenant une thiouree pour son utilisation en tant que depigmentant

Also Published As

Publication number Publication date
FR2881654A1 (fr) 2006-08-11

Similar Documents

Publication Publication Date Title
EP2154971A4 (fr) Combinaison pharmaceutique synergique pour le traitement du cancer
EP2322221A4 (fr) Composition pharmaceutique pour le traitement et la prévention du cancer
PT2601962T (pt) Regime de dosagem de lag-3 para utilização no tratamento de cancro
EP2125855A4 (fr) Procédés et compositions pour le traitement du cancer ou d&#39;autres maladies
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
HK1102544A1 (en) Use of herbal compositions in the manufacture of medicine for treating prostate cancer
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
EP1869222A4 (fr) Marqueur de méthylation pour le diagnostic et le traitement des cancers
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
HUE059861T2 (hu) N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra
GB2453011B (en) Antifolate agent compositions in the treatment of cancer
CL2007000806A1 (es) Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer.
IL218317A0 (en) Use of compositions containing il-15 polypeptide and il-15 containing complexes for the treatment of cancer
EP1967209A4 (fr) Agent thérapeutique pour le cancer de la prostate
EP2010572A4 (fr) Compositions contenant des polypeptides hpv et des peptides d&#39;immunostimulation pour le traitement et la prévention du cancer du col de l&#39;utérus
HK1105886A1 (en) Pharmaceutical compositions comprising l-733060 for use in the treatment of cancer tumours l-733060
EP2493896A4 (fr) Composition pharmaceutique contenant des complexes cyclométallés de carbènes n-hétérocycliques pour le traitement du cancer
EP1996612A4 (fr) Compositions destinee au traitement des cancers
EP2217697A4 (fr) Utilisation des antagonistes de lingo-4 dans le traitement d&#39;états mettant en jeu une démyélination
DE602004020070D1 (de) Thienopyrimidin-derivate als kaliumkanal-inhibitoren
FR2869540B1 (fr) Compositions pharmaceutiques contenant des derives de b-carboline, et leur utilisation pour le traitement des cancers
EP2254411A4 (fr) Inhibiteurs du complément en tant qu&#39;agents thérapeutiques pour le traitement du cancer
EP2211861A4 (fr) Clioquinol dans le traitement de malignités hématologiques
EP1870404A4 (fr) Agent pour le traitement d&#39;une tumeur hématopoïétique
DE602006013009D1 (de) Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property

Owner name: ETHNODYNE, FR

Effective date: 20120625

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20